Ulta Lab Tests

AspirinWorks® 11-Dehydrothromboxane B2 Test with Creatinine

The AspirinWorks® 11-Dehydrothromboxane B2 Test with Creatinine measures urinary levels of 11-dehydrothromboxane B2, a biomarker of platelet activation. This test helps assess the effectiveness of aspirin therapy and detect aspirin resistance. By adjusting for creatinine, it provides an accurate reflection of thromboxane production, supporting cardiovascular risk management and treatment monitoring.

Random
Phlebotomist
11-dhTXB2 Test
There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Specimen Type: Random

Also known as: Aspirin Resistance 11Dehydrothromboxane B2

11 Dehydrothromboxane B2

11DHTXB2

Creatinine, Random Urine

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through a national lab. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The AspirinWorks® 11-Dehydrothromboxane B2 Test with Creatinine test contains 1 test with 3 biomarkers .

Aspirin (which inhibits platelet cyclo-oxygenase) reduces the risk of thrombosis in cardiovascular disease by impairing platelet function. Patients who do not respond to the platelet inhibitory effects of aspirin are designated as "ASPIRIN RESISTANT". The measurement of 11-DEHYDROTHROMBOXANE B2 in urine (the principal metabolite of platelet cyclo-oxygenase derived thromboxane B2) indicates lack of aspirin responsiveness.

Customer Reviews